Accreditation Information: Sinus Forum 2010
INTENDED AUDIENCE
Rhinologists, General ENT physicians, ENT fellows, ENT facial plastic surgeons
PHYSICIAN ACCREDITATION STATEMENT
PRIME® is accredited by the ACCME to provide continuing medical education for physicians.
Designation of Credit
PRIME® designates this educational activity for a maximum of 7.0 AMA PRA Category 1 Credit (s) ™.
Physician Assistant Accreditation Statement
AAPA accepts AMA Category 1 CME Credit™ for the PRA from organizations accredited by ACCME.
Release and Expiration Date for Enduring Materials
These activities were originally released on July 16, 2010 and is accredited until July 16, 2011.
Disclosure Statements
PROGRAM PLANNERS
Disclosure Information | Advisory Board | Consultant | Grants / Research | Salary / Contractual | Supported CME/CE | Supported Promotional Education | Stock / Shareholder | Other Financial Support |
| Howard L.Levine,MD,FACS Planner | Acclarent, Inc., Carbylan Biosurgery, Arthrocare Corporation | Rhino Systems, Inc. Acclarent, Inc. | None | None | Acclarent | None | Rhino Systems, Inc. | None |
| Mark E. Mehle, MD, FACS Speaker | None | Arbor | None | None | Acclarent | GSK, Merck, Alcon, Sepacor | None | None |
William E. Bolger, MD | Acclarent | None | None | None | Acclarent | None | None | None |
| Michael J. Rutter, MD | Acclarent | None | None | None | Acclarent | None | None | None |
| Steven M. Houser, MD | None | None | None | None | Acclarent | None | None | None |
| Ashley Sikand, MD | None | Acclarent | Acclarent | None | Acclarent | Acclarent, Alcon | None | None |
| John Fornadley, MD | None | None | None | None | Acclarent | Alcon | Glaxo, Johnson & Johnson | None |
| ArthurElkind, MD | None | None | None | None | Acclarent | None | None | None |
| Michael Sillers, MD | Acclarent, GE Navigation | None | None | None | Acclarent | Xoran Technologies | None | None |
Lee Mandel, MD | None | None | None | None | Acclarent | None | None | None |
| JamesStankiewicz,MD | Entellus | Gyrus-Olympus | None | None | Acclarent | None | None | None |
| Michael Setzen, MD, FACS, FAAP | None | None | None | None | Acclarent | None | None | None |
| Timothy Anderson,MD | None | None | None | None | Acclarent | None | None | None |
| Vincent Chan, MD | None | None | None | None | Acclarent | None | None | None |
| FrankG Kronberg,MD, FACS Peer Reviewer | None | None | None | None | None | GlaxoSmithKline PricCara Ortho-McNeil-Janssen Pharmaceuticals,In | None | None |
| Lynn Goldenberg, RN, BSN PRIME® Staff | None | None | None | None | None | None | None | None |
Fees for Participation
There is no fee for this program. This program is sponsored by PRIME Education, Inc., through an educational grant from Acclarent.
PRIME DISCLOSURE STATEMENT
PRIME Education, Inc., (PRIME®) endorses the standards of the ACCME, as well as those of the AANP, ANCC and ACPE, that require everyone in a position to control the content of a CME/CE activity to disclose all financial relationships with commercial interests that are related to the content of the CME/CE activity. CME/CE activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.
A conflict of interest is created when individuals in a position to control the content of CME/CE have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
PRIME® will identify, review and resolve all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for speakers, authors, course directors, planners, peer reviewers, and/or relevant staff are provided with this activity.
Presentations that provide information in whole or in part related to non FDA approved uses of drugs and/or devices will disclose the unlabeled indications or the investigational nature of their proposed uses to the audience. Participants should refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Participants should verify all information and data before treating patients or employing any therapies prescribed in this educational activity. The opinions expressed in the educational activity are those of the presenting faculty and do not necessarily represent the views of PRIME®, the ACCME, AANP, ACPE, ANCC and other relevant accreditation bodies.
METHOD OF PARTICIPATION
CME awards will require pre-registration for the program, completion of the learner assessment tool, attendance of the activity in its entirety, and completion of a program evaluation at www.thesinusforun.com. After fulfilling these requirements, you will be able to print your CME certificate.
